CITA Biomedical, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CITA Biomedical, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tim Davies who wrote (10)	8/12/2002 4:50:07 PM
From: jmhollen	Read Replies (1) of 19

Probably related to costs. If they can get a number of successful cases documented, they can probably get some Fed or Pharm money to do a complete clinical trails program. That should be worth a " synergy deal" and/or a few productive PRs, one would think. Share price seems to be holding OK in the interim. This is another of those "..Casino Money only.." stocks, until they start getting some recognition from the MD and Professional Clinic/Treatment Center community. John :-) .

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next